McMaster University (Dr. J. Valliant)

experts.mcmaster.ca
Innovation Type:
Therapeutics
Cancer Type:
Multiple
Funding Stage:
Proof of Concept
Fund:
Compass Rose
Radiolabeled Insulin Probe - Insulin-like growth factor receptor 1 molecule labelled with 99-Technicium for gamma scan as a functional replacement to costly 18-FDG PET scan for tumour metabolic activity.

Related news

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.